Technical Analysis for SYBX - Synlogic, Inc.

Grade Last Price % Change Price Change
grade F 7.24 1.83% 0.13
SYBX closed up 1.83 percent on Friday, January 18, 2019, on 43 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SYBX trend table...

Date Alert Name Type % Chg
Jan 18 Hammer Candlestick Bullish 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Fell Below 20 DMA Bearish 1.83%
Jan 17 MACD Bearish Signal Line Cross Bearish 1.83%
Jan 17 Wide Bands Range Expansion 1.83%
Jan 16 Crossed Above 20 DMA Bullish -2.69%
Jan 16 Wide Bands Range Expansion -2.69%
Jan 15 20 DMA Resistance Bearish 0.42%
Jan 15 MACD Bearish Centerline Cross Bearish 0.42%

Older signals for SYBX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Synlogic, Inc., formerly Mirna Therapeutics, Inc., is engaged in the development of a novel class of living treatments, Synthetic Biotic medicines. The Company uses its proprietary Synthetic Biotic development platform. Its pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). It is also focused on Synthetic Biotic medicines to address other conditions, including inflammatory bowel disease , cancer and metabolic conditions, such as diabetes and obesity. The Company’s synthetic biotic medicines leverages the tools and principles of synthetic biology to genetically reengineer probiotic microbes to perform or deliver critical functions missing or damaged due to disease. The Company’s pipeline includes synthetic biotic medicines for the treatment of inborn errors of metabolism (IEM). It is developing SYNB1020 for the treatment of UCD and HE. It is developing SYNB1618 for the treatment of PKU.
Is SYBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.59
52 Week Low 5.75
Average Volume 119,712
200-Day Moving Average 9.8844
50-Day Moving Average 7.8364
20-Day Moving Average 7.426
10-Day Moving Average 7.762
Average True Range 0.6568
ADX 9.81
+DI 20.6976
-DI 21.6341
Chandelier Exit (Long, 3 ATRs ) 7.0296
Chandelier Exit (Short, 3 ATRs ) 7.7204
Upper Bollinger Band 8.7499
Lower Bollinger Band 6.1021
Percent B (%b) 0.43
BandWidth 35.655804
MACD Line -0.1038
MACD Signal Line -0.0757
MACD Histogram -0.0281
Fundamentals Value
Market Cap 117.88 Million
Num Shares 16.3 Million
EPS -9.33
Price-to-Earnings (P/E) Ratio -0.78
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.72
Resistance 3 (R3) 7.67 7.47 7.64
Resistance 2 (R2) 7.47 7.34 7.49 7.61
Resistance 1 (R1) 7.35 7.27 7.41 7.40 7.59
Pivot Point 7.15 7.15 7.18 7.17 7.15
Support 1 (S1) 7.03 7.02 7.09 7.08 6.89
Support 2 (S2) 6.83 6.95 6.85 6.87
Support 3 (S3) 6.71 6.83 6.84
Support 4 (S4) 6.76